NowRx and its executives were hit with a securities class action on Nov. 4 in New York Southern District Court. The suit, brought by Squitieri & Fearon and Moore Law, alleges that the defendants made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results